Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
The physician has responded that the cause of the sleep apnea and breathing difficulties is due to vns stimulation, and that the disablement was done to preclude serious injury.Settings were provided.No device malfunction was indicated, the lead impedance is assumed to be within normal limits.No other relevant information has been received to date.
|